USA |NASDAQ |USD
Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
---|---|---|---|---|
Aug 8, 2022 | Jun 2022 | - | - | $-0.80 |
Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
---|---|---|---|---|
Aug 8, 2022 | Jun 2022 | - | - | $0.00 |
Gossamer Bio's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|---|---|---|---|
Dec 2022 | 8 | $-3.09 | $-3.52 | $-2.75 |
Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
---|
Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
---|---|---|---|---|
Dec 2022 | 2 / 1 | $-2.94 | $-2.94 | $-3.03 |
Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
---|
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|---|---|---|---|
Dec 2022 | 8 | $0.00 | $0.00 | $0.00 |
Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
---|---|---|---|---|
May 4, 2022 | Mar 2022 | $-0.78 | - | - |
Mar 3, 2022 | Dec 2021 | $-0.74 | $-0.74 | - |
Nov 8, 2021 | Sep 2021 | $-0.78 | $-0.80 | -2.30% |
Aug 9, 2021 | Jun 2021 | $-0.76 | $-0.80 | -5.61% |
May 6, 2021 | Mar 2021 | $-0.77 | $-0.78 | -1.96% |
Feb 25, 2021 | Dec 2020 | $-0.79 | $-0.88 | -11.68% |
Nov 10, 2020 | Sep 2020 | $-0.84 | $-0.80 | 5.21% |
Aug 11, 2020 | Jun 2020 | $-0.82 | $-1.00 | -21.65% |
May 12, 2020 | Mar 2020 | $-0.75 | $-0.87 | -16.00% |
Mar 24, 2020 | Dec 2019 | $-0.82 | $-0.89 | -8.80% |
Nov 12, 2019 | Sep 2019 | $-0.70 | $-0.80 | -15.11% |
Aug 8, 2019 | Jun 2019 | $-0.56 | $-0.74 | -32.14% |
May 14, 2019 | Mar 2019 | $-0.66 | $-0.90 | -37.40% |
Mar 22, 2019 | Dec 2018 | $-1.37 | $-1.39 | -1.46% |
Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
---|---|---|---|---|
Mar 3, 2022 | Dec 2021 | $-3.11 | $-3.12 | - |
Feb 25, 2021 | Dec 2020 | $-3.50 | $-3.55 | - |
Mar 24, 2020 | Dec 2019 | $-3.18 | $-3.33 | - |
Mar 22, 2019 | Dec 2018 | $-4.65 | $-1.39 | - |
Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
---|---|---|---|---|
May 4, 2022 | Mar 2022 | $0.00 | - | - |
Mar 3, 2022 | Dec 2021 | $0.00 | - | - |
Nov 8, 2021 | Sep 2021 | $0.00 | $0.00 | - |
Aug 9, 2021 | Jun 2021 | $0.00 | $0.00 | - |
May 6, 2021 | Mar 2021 | $0.00 | $0.00 | - |
Feb 25, 2021 | Dec 2020 | $0.00 | $0.00 | - |
Nov 10, 2020 | Sep 2020 | $0.00 | $0.00 | - |
Aug 11, 2020 | Jun 2020 | $0.00 | $0.00 | - |
May 12, 2020 | Mar 2020 | $0.00 | $0.00 | - |
Mar 24, 2020 | Dec 2019 | $0.00 | $0.00 | - |
Nov 12, 2019 | Sep 2019 | $0.00 | $0.00 | - |
Aug 8, 2019 | Jun 2019 | $0.00 | $0.00 | - |
May 14, 2019 | Mar 2019 | $0.00 | $0.00 | - |
Mar 22, 2019 | Dec 2018 | $0.00 | $0.00 | - |
Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
---|---|---|---|---|
Mar 3, 2022 | Dec 2021 | $0.00 | - | - |
Feb 25, 2021 | Dec 2020 | $0.00 | $0.00 | - |
Mar 24, 2020 | Dec 2019 | $0.00 | $0.00 | - |
Mar 22, 2019 | Dec 2018 | $0.00 | $0.00 | - |
GOSS's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.
Gossamer Bio's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.
Gossamer Bio's previous annual earnings date was Mar 3, 2022 for its fiscal year ended Dec 31, 2021.
GOSS's earnings per share (EPS) was $-3.12, missing the consensus analysts forecast of $-3.11 by 0.32% , and higher than the previous year's EPS (Dec 2020) by -12.11%.
The company reported a net income of $-234.00M.
Gossamer Bio reported a free cash flow of $-190.44M for its fiscal year, compared to $-201.24M a year ago.
The company ended the fiscal year with $150.04M in total debt, a decrease of -14.76% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.